Cite this paper
Sugamata, M. , Ihara, T. and Uchiide, I. (2015) A New Therapy for Human Endometriosis: The Therapeutic Value of Leukotriene Receptor Antagonist for Endometriosis.
Open Journal of Obstetrics and Gynecology,
5, 313-318. doi:
10.4236/ojog.2015.56045.
References
[1] Houston, D.E., Noller, K.L., Melton III, L.J. and Selwyn, B.J. (1988) The Epidemiology of Pelvic Endometriosis. Clinical Obstetrics and Gynecology, 31, 787-800.
http://dx.doi.org/10.1097/00003081-198812000-00005
[2] Dmownski, W.P., Braum, D. and Gebel, H.M. (1990) Endometriosis: Genetics and Immunologic Aspects. Current Concepts in Endometriosis. Alan R Liss, New York, 99-122.
[3] Sugamata, M., Ihara, T. and Uchiide, I. (2005) Increase of Activated Mast Cells in Human Endometriosis. American Journal of Reproductive Immunology, 53, 120-125.
http://dx.doi.org/10.1111/j.1600-0897.2005.00254.x
[4] Uchiide, I., Ihara, T. and Sugamata, M. (2002) Pathological Evaluation of Rat Endometriosis Model. Fertility and Sterility, 78, 782-786.
http://dx.doi.org/10.1016/S0015-0282(02)03327-7
[5] Ihara, T., Uchiide, I. and Sugamata, M. (2004) Light and Electron Microscopic Evaluation of Antileukotriene Therapy for Experimental Rat Endometriosis. Fertility and Sterility, 81, 819-823.
http://dx.doi.org/10.1016/j.fertnstert.2003.08.029
[6] The American Fertility Society (1985) Revised American Fertility Society Classification of Endometriosis. Fertility and Sterility, 43, 351-352.
[7] Fawcett, D.W. and Jensh, R.P. (1997) Bloom & Fawcett: Concise Histology. Chapman & Hall, New York, 51-52.
[8] Ihara, T., Yamamoto, T., Sugamata, M., Okumura, H. and Ueno, Y. (1998) The Process of Ultrastructural Change from Nuclei to Apoptotic Body. Virchows Arch, 433, 443-447.
http://dx.doi.org/10.1007/s004280050272
[9] Benebetto, C. (1989) Eicosanoids in Primary Dysmenorrheal, Endometriosis and Menstrual Migraine. Gynecological Endocrinology, 3, 71-94.
http://dx.doi.org/10.3109/09513598909152454
[10] Yamaguchi, M. and Mori, N. (1990) Prostaglandin and Leukotriene Concentration of the Peritoneal Fluid of Endometriosis and Other Gynecologic Disorders in Secretory Phase. Prostaglandins, Leukotrienes and Essential Fatty Acids, 39, 43-45.
http://dx.doi.org/10.1016/0952-3278(90)90170-P
[11] Karim, S.M. and Hillier, K. (1979) Prostaglandins in the Control of Animal and Human Reproduction. British Medical Bulletin, 35, 173-180.
[12] Fakih, H., Baggett, B., Holtz, G., Tsang, K.Y., Lee, J.C. and Williamson, H.O. (1987) Interleukin-1: A Possible Role in the Infertility Associated with Endometriosis. Fertility and Sterility, 47, 213-217.
[13] Ota, H., Igarashi, S., Hatazawa, J. and Taka, T. (1999) Immunohistochemical Assessmeny of Superoxide Dismutase Expression in the Endometrium in Endometriosis and Adenomyosis. Fertility and Sterility, 72, 129-134.
http://dx.doi.org/10.1016/S0015-0282(99)00152-1